Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Valvular Heart Disease

Free Subscription Articles published in Circulation Retrieve available abstracts of 122 articles: HTML format

Single Articles

April 2022
1. DIEDERICHSEN ACP, Lindholt JS, Moller S, Ovrehus KA, et al
   Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial.
   Circulation. 2022 Apr 25. doi: 10.1161/CIRCULATIONAHA.121.057008.
   PubMed     Abstract available
   
   
   
2. RIAZ M, Park J, Sewanan LR, Ren Y, et al
   Muscle LIM Protein Force-Sensing Mediates Sarcomeric Biomechanical Signaling in Human Familial Hypertrophic Cardiomyopathy.
   Circulation. 2022;145:1238-1253.
   PubMed     Abstract available
   
   
   
3. TRIMAILLE A, Hmadeh S, Morel O
   Letter by Trimaille et al Regarding Article, "Native Aortic Valve Disease Progression and Bioprosthetic Valve Degeneration in Patients With Transcatheter Aortic Valve Implantation".
   Circulation. 2022;145:e807-e808.
   PubMed    
   
   
   
4. REED AK, Chiu P, Carreon CK, Sanders SP, et al
   Unrepairable Infant Mitral Valve: An Unexpected Case of Decompensated Heart Failure.
   Circulation. 2022;145:1175-1178.
   PubMed    
   
   
   
5. KWIECINSKI J, Tzolos E, Bing R, Dweck MR, et al
   Response by Kwiecinski et al to Letter Regarding Article, "Native Aortic Valve Disease Progression and Bioprosthetic Valve Degeneration in Patients With Transcatheter Aortic Valve Implantation".
   Circulation. 2022;145:e809-e810.
   PubMed    
   
   
   March 2022
6. HILLIS GS, McCann GP, Newby DE
   Is Asymptomatic Severe Aortic Stenosis Still a Waiting Game?
   Circulation. 2022;145:874-876.
   PubMed    
   
   
   
7. 
   Correction to: Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis: The AVATAR Trial.
   Circulation. 2022;145:e761.
   PubMed    
   
   
   February 2022
8. RABER I, Palmeri NO, Tahir UA, Zimetbaum PJ, et al
   A Pacemaker Red Herring and a Hypertrophic Cardiomyopathy Copycat.
   Circulation. 2022;145:622-625.
   PubMed    
   
   
   
9. PASSOS LSA, Jha PK, Becker-Greene D, Blaser MC, et al
   Prothymosin Alpha: A Novel Contributor to Estradiol Receptor Alpha-Mediated CD8(+) T-Cell Pathogenic Responses and Recognition of Type 1 Collagen in Rheumatic Heart Valve Disease.
   Circulation. 2022;145:531-548.
   PubMed     Abstract available
   
   
   January 2022
10. VIJ A, Kavinsky CJ
    The Clinical Impact of Device Lead-Associated Tricuspid Regurgitation: Need for a Multidisciplinary Approach.
    Circulation. 2022;145:239-241.
    PubMed    
    
    
    
11. AGUADO BA, Walker CJ, Grim JC, Schroeder ME, et al
    Genes that Escape X Chromosome Inactivation Modulate Sex Differences in Valve Myofibroblasts.
    Circulation. 2022 Jan 10. doi: 10.1161/CIRCULATIONAHA.121.054108.
    PubMed     Abstract available
    
    
    December 2021
12. BERNDT N, Eckstein J, Wallach I, Nordmeyer S, et al
    CARDIOKIN1: Computational Assessment of Myocardial Metabolic Capability in Healthy Controls and Patients With Valve Diseases.
    Circulation. 2021;144:1926-1939.
    PubMed     Abstract available
    
    
    November 2021
13. SPIERING W, Mali WP, de Jong PA
    Letter by Spiering et al Regarding Article, "Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial".
    Circulation. 2021;144:e334.
    PubMed    
    
    
    
14. BING R, Newby DE, Ralston SH, Dweck MR, et al
    Response by Bing et al to Letter Regarding Article, "Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial".
    Circulation. 2021;144:e335.
    PubMed    
    
    
    
15. RANJBARVAZIRI S, Kooiker KB, Ellenberger M, Fajardo G, et al
    Altered Cardiac Energetics and Mitochondrial Dysfunction in Hypertrophic Cardiomyopathy.
    Circulation. 2021;144:1714-1731.
    PubMed     Abstract available
    
    
    
16. RAMAN B, Tunnicliffe EM, Chan K, Ariga R, et al
    Association Between Sarcomeric Variants in Hypertrophic Cardiomyopathy and Myocardial Oxygenation: Insights From a Novel Oxygen-Sensitive Cardiovascular Magnetic Resonance Approach.
    Circulation. 2021;144:1656-1658.
    PubMed    
    
    
    
17. BANOVIC M, Putnik S, Penicka M, Doros G, et al
    Aortic Valve ReplAcemenT versus Conservative Treatment in Asymptomatic SeveRe Aortic Stenosis: The AVATAR Trial.
    Circulation. 2021 Nov 13. doi: 10.1161/CIRCULATIONAHA.121.057639.
    PubMed     Abstract available
    
    
    
18. ABDEL-WAHAB M, Hartung P, Dumpies O, Obradovic D, et al
    Comparison of a Pure Plug-Based versus a Primary Suture-Based Vascular Closure Device Strategy for Transfemoral Transcatheter Aortic Valve Replacement: The CHOICE-CLOSURE Randomized Clinical Trial.
    Circulation. 2021 Nov 5. doi: 10.1161/CIRCULATIONAHA.121.057856.
    PubMed     Abstract available
    
    
    October 2021
19. BELHASSEN B, Shauer A, Biton Y
    Left Bundle-Branch Block Tachycardia After Transcatheter Aortic Valve Replacement.
    Circulation. 2021;144:1444-1448.
    PubMed    
    
    
    September 2021
20. DANIELS MJ, Fusi L, Semsarian C, Naidu SS, et al
    Myosin Modulation in Hypertrophic Cardiomyopathy and Systolic Heart Failure: Getting Inside the Engine.
    Circulation. 2021;144:759-762.
    PubMed    
    
    
    August 2021
21. AGUIB Y, Allouba M, Walsh R, Ibrahim AM, et al
    New Variant With a Previously Unrecognized Mechanism of Pathogenicity in Hypertrophic Cardiomyopathy.
    Circulation. 2021;144:754-757.
    PubMed    
    
    
    
22. KWIECINSKI J, Tzolos E, Cartlidge TRG, Fletcher A, et al
    Native Aortic Valve Disease Progression and Bioprosthetic Valve Degeneration in Patients with Transcatheter Aortic Valve Implantation.
    Circulation. 2021 Aug 29. doi: 10.1161/CIRCULATIONAHA.121.056891.
    PubMed     Abstract available
    
    
    
23. MANISTY CH, Jordan JH, Hundley WG
    Automated Noncontrast Myocardial Tissue Characterization for Hypertrophic Cardiomyopathy: Holy Grail or False Prophet?
    Circulation. 2021;144:600-603.
    PubMed    
    
    
    
24. EZEKOWITZ JA
    Residuals: Mitral Regurgitation, Bias, and Effects of Medical Therapy.
    Circulation. 2021;144:438-440.
    PubMed    
    
    
    July 2021
25. KUMBHANI DJ, Peterson ED
    Sequential Evolution of Quality Assessment for Aortic Valvular Heart Interventions.
    Circulation. 2021;144:195-198.
    PubMed    
    
    
    
26. DESAI ND, O'Brien SM, Cohen DJ, Carroll J, et al
    Composite Metric for Benchmarking Site Performance in Transcatheter Aortic Valve Replacement: Results From the STS/ACC TVT Registry.
    Circulation. 2021;144:186-194.
    PubMed     Abstract available
    
    
    
27. ZHANG Q, Burrage MK, Lukaschuk E, Shanmuganathan M, et al
    Towards Replacing Late Gadolinium Enhancement with Artificial Intelligence Virtual Native Enhancement for Gadolinium-Free Cardiovascular Magnetic Resonance Tissue Characterization in Hypertrophic Cardiomyopathy.
    Circulation. 2021 Jul 7. doi: 10.1161/CIRCULATIONAHA.121.054432.
    PubMed     Abstract available
    
    
    June 2021
28. DEMER LL, Tintut Y
    Hearts of Stone: Calcific Aortic Stenosis and Antiresorptive Agents for Osteoporosis.
    Circulation. 2021;143:2428-2430.
    PubMed    
    
    
    
29. WATKINS H
    Time to Think Differently About Sarcomere-Negative Hypertrophic Cardiomyopathy.
    Circulation. 2021;143:2415-2417.
    PubMed    
    
    
    
30. TAM DY, Wijeysundera HC
    A Real-World Examination of Embolic Protection Devices for Transcatheter Aortic Valve Replacement.
    Circulation. 2021;143:2241-2243.
    PubMed    
    
    
    May 2021
31. KAR S, Mack MJ, Lindenfeld J, Abraham WT, et al
    Relationship Between Residual Mitral Regurgitation and Clinical and Quality-of-Life Outcomes After Transcatheter and Medical Treatments in Heart Failure: The COAPT Trial.
    Circulation. 2021 May 27. doi: 10.1161/CIRCULATIONAHA.120.053061.
    PubMed     Abstract available
    
    
    
32. SHROFF GR, Bangalore S, Bhave NM, Chang TI, et al
    Evaluation and Management of Aortic Stenosis in Chronic Kidney Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2021 May 13:CIR0000000000000979. doi: 10.1161/CIR.0000000000000979.
    PubMed     Abstract available
    
    
    April 2021
33. PAWADE TA, Doris MK, Bing R, White AC, et al
    Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial.
    Circulation. 2021 Apr 29. doi: 10.1161/CIRCULATIONAHA.121.053708.
    PubMed     Abstract available
    
    
    
34. LINDMAN BR, Merryman WD
    Unloading the Stenotic Path to Identifying Medical Therapy for Calcific Aortic Valve Disease: Barriers and Opportunities.
    Circulation. 2021;143:1455-1457.
    PubMed    
    
    
    March 2021
35. KIM WK, Walther T, Burgdorf C, Mollmann H, et al
    One-Year Outcomes of a Randomized Trial Comparing a Self-Expanding With a Balloon-Expandable Transcatheter Aortic Valve.
    Circulation. 2021;143:1267-1269.
    PubMed    
    
    
    
36. MARON MS, Ommen SR
    Exploring New and Old Therapies for Obstructive Hypertrophic Cardiomyopathy: Mavacamten in Perspective.
    Circulation. 2021;143:1181-1183.
    PubMed    
    
    
    
37. GRACE A, Mellor G, Williams L
    Letter by Grace et al Regarding Article, "A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy".
    Circulation. 2021;143:e786-e787.
    PubMed    
    
    
    
38. MITAL S, Armstrong KR, Butts RJ, Conway J, et al
    Response by Mital et al to Letter Regarding Article, "A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy".
    Circulation. 2021;143:e788-e789.
    PubMed    
    
    
    
39. CONSTANT DIT BEAUFILS AL, Huttin O, Jobbe-Duval A, Senage T, et al
    Replacement Myocardial Fibrosis in Patients with Mitral Valve Prolapse: Relation to Mitral Regurgitation, Ventricular Remodeling and Arrhythmia.
    Circulation. 2021 Mar 12. doi: 10.1161/CIRCULATIONAHA.120.050214.
    PubMed     Abstract available
    
    
    
40. 
    Correction to: 2020 ACC/AHA Guideline on the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2021;143:e784.
    PubMed    
    
    
    
41. VINCENT F, Ternacle J, Denimal T, Shen M, et al
    Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Stenosis.
    Circulation. 2021;143:1043-1061.
    PubMed     Abstract available
    
    
    February 2021
42. BUTALA NM, Makkar R, Secemsky EA, Gallup D, et al
    Cerebral Embolic Protection and Outcomes of Transcatheter Aortic Valve Replacement: Results from the TVT Registry.
    Circulation. 2021 Feb 23. doi: 10.1161/CIRCULATIONAHA.120.052874.
    PubMed     Abstract available
    
    
    
43. WORKMAN V, Forrest JK, Enriquez A
    A Case of Presyncope After Transcatheter Aortic Valve Replacement.
    Circulation. 2021;143:857-861.
    PubMed    
    
    
    
44. SHAH SV, Bavry AA, Kumbhani DJ
    Transcatheter Mitral Valve Edge-to-Edge Repair for Secondary Mitral Regurgitation: Why Sex Matters.
    Circulation. 2021;143:621-623.
    PubMed    
    
    
    
45. SABERI S, Cardim N, Yamani M, Schulz-Menger J, et al
    Mavacamten Favorably Impacts Cardiac Structure in Obstructive Hypertrophic Cardiomyopathy: EXPLORER-HCM Cardiac Magnetic Resonance Substudy Analysis.
    Circulation. 2021;143:606-608.
    PubMed    
    
    
    
46. 
    Correction to: 2020 ACC/AHA Guideline on the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2021;143:e228.
    PubMed    
    
    
    
47. 
    Correction to: 2020 ACC/AHA Guideline on the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2021;143:e229.
    PubMed    
    
    
    January 2021
48. HO CY
    Guidelines on the Verge of a More Evidence-Based Era for Hypertrophic Cardiomyopathy.
    Circulation. 2021;143:295-297.
    PubMed    
    
    
    
49. MESSAS E, IJsselmuiden A, Goudot G, Vlieger S, et al
    Feasibility and Performance of Noninvasive Ultrasound Therapy in Patients With Severe Symptomatic Aortic Valve Stenosis: A First-in-Human Study.
    Circulation. 2021 Jan 25. doi: 10.1161/CIRCULATIONAHA.120.050672.
    PubMed    
    
    
    
50. FORTUNI F, Bax JJ, Delgado V
    Changing the Paradigm in the Management of Valvular Heart Disease: In Addition to Left Ventricular Ejection Fraction, Focus on the Myocardium.
    Circulation. 2021;143:209-211.
    PubMed    
    
    
    
51. URENA M, Vahanian A, Brochet E, Ducrocq G, et al
    Current Indications for Transcatheter Mitral Valve Replacement Using Transcatheter Aortic Valves: Valve-in-Valve, Valve-in-Ring, and Valve-in-Mitral Annulus Calcification.
    Circulation. 2021;143:178-196.
    PubMed     Abstract available
    
    
    
52. BAPAT VN
    Mitral Valve-in-Valve, Valve-in-Ring, and Valve-in-Mitral Annular Calcification: Are We There Yet?
    Circulation. 2021;143:117-119.
    PubMed    
    
    
    
53. PELLICCIA F, Gersh BJ, Camici PG
    Gaps in Evidence for Risk Stratification for Sudden Cardiac Death in Hypertrophic Cardiomyopathy.
    Circulation. 2021;143:101-103.
    PubMed    
    
    
    December 2020
54. OTTO CM, Nishimura RA, Bonow RO, Carabello BA, et al
    2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2020 Dec 17:CIR0000000000000923. doi: 10.1161/CIR.0000000000000923.
    PubMed    
    
    
    
55. OTTO CM, Nishimura RA, Bonow RO, Carabello BA, et al
    2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2020 Dec 17:CIR0000000000000932. doi: 10.1161/CIR.0000000000000932.
    PubMed     Abstract available
    
    
    
56. BAVRY AA, Arnaoutakis GJ
    Perspective to 2020 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease.
    Circulation. 2020 Dec 17. doi: 10.1161/CIRCULATIONAHA.120.051501.
    PubMed    
    
    
    
57. MEHMOOD M
    Letter by Mehmood Regarding Article, "Cardiac Energetics in Patients With Aortic Stenosis and Preserved Versus Reduced Ejection Fraction".
    Circulation. 2020;142:e375-e376.
    PubMed    
    
    
    
58. PETERZAN MA, Neubauer S, Rodgers CT, Rider OJ, et al
    Response by Peterzan et al to Letter Regarding Article, "Cardiac Energetics in Patients With Aortic Stenosis and Preserved Versus Reduced Ejection Fraction".
    Circulation. 2020;142:e377-e378.
    PubMed    
    
    
    November 2020
59. USEINI D, Strauch J
    Letter by Useini and Strauch Regarding Article, "Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial".
    Circulation. 2020;142:e310-e311.
    PubMed    
    
    
    
60. LOARDI C, Zanobini M
    Letter by Loardi and Zanobini Regarding Article, "Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial".
    Circulation. 2020;142:e312-e313.
    PubMed    
    
    
    
61. PIBAROT P, Mack MJ, Leon MB, Hahn RT, et al
    Response by Pibarot et al to Letter Regarding Article, "Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial".
    Circulation. 2020;142:e314-e315.
    PubMed    
    
    
    
62. POLLARI F, Vogt F, Fischlein T
    Letter by Pollari et al Regarding Article, "Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial".
    Circulation. 2020;142:e308-e309.
    PubMed    
    
    
    
63. KARTHIKEYAN G, Connolly SJ, Yusuf S
    Overestimation of Stroke Risk in Rheumatic Mitral Stenosis and the Implications for Oral Anticoagulation.
    Circulation. 2020;142:1697-1699.
    PubMed    
    
    
    October 2020
64. LURZ P, Unterhuber M, Rommel KP, Kresoja KP, et al
    Closure of Iatrogenic Atrial Septal Defect Following Transcatheter Mitral Valve Repair: The Randomized MITHRAS Trial.
    Circulation. 2020 Oct 15. doi: 10.1161/CIRCULATIONAHA.120.051989.
    PubMed    
    
    
    
65. TAMBURINO C, Bleiziffer S, Thiele H, Scholtz S, et al
    Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients with Symptomatic Severe Aortic Stenosis: The SCOPE 2 Randomized Clinical Trial.
    Circulation. 2020 Oct 15. doi: 10.1161/CIRCULATIONAHA.120.051547.
    PubMed     Abstract available
    
    
    
66. DEL VAL D, Linke A, Abdel-Wahab M, Latib A, et al
    Long-Term Outcomes After Infective Endocarditis After Transcatheter Aortic Valve Replacement.
    Circulation. 2020;142:1497-1499.
    PubMed    
    
    
    
67. CHAN V, Mazer CD, Ali FM, Quan A, et al
    Randomized, Controlled Trial Comparing Mitral Valve Repair With Leaflet Resection Versus Leaflet Preservation on Functional Mitral Stenosis: The CAMRA CardioLink-2 Study.
    Circulation. 2020;142:1342-1350.
    PubMed     Abstract available
    
    
    
68. HANZEL GS, Gersh BJ
    Transcatheter Aortic Valve Replacement in Low-Risk, Young Patients: Natural Expansion or Cause for Concern?
    Circulation. 2020;142:1317-1319.
    PubMed    
    
    
    September 2020
69. SIMONATO M, Whisenant B, Barbosa Ribeiro H, Webb JG, et al
    Transcatheter Mitral Valve Replacement After Surgical Repair or Replacement: Comprehensive Mid-Term Evaluation of Valve-in-Valve and Valve-in-Ring Implantation from the VIVID Registry.
    Circulation. 2020 Sep 25. doi: 10.1161/CIRCULATIONAHA.120.049088.
    PubMed     Abstract available
    
    
    August 2020
70. THIELE H, Kurz T, Feistritzer HJ, Stachel G, et al
    General versus Local Anesthesia with Conscious Sedation in Transcatheter Aortic Valve Implantation: The Randomized SOLVE-TAVI Trial.
    Circulation. 2020 Aug 21. doi: 10.1161/CIRCULATIONAHA.120.046451.
    PubMed     Abstract available
    
    
    
71. TUCKER NR, Chaffin M, Bedi KC Jr, Papangeli I, et al
    Myocyte-Specific Upregulation of ACE2 in Cardiovascular Disease: Implications for SARS-CoV-2-Mediated Myocarditis.
    Circulation. 2020;142:708-710.
    PubMed    
    
    
    July 2020
72. MICHELENA HI, Vallabhajosyula S, Prakash SK
    Nosology Spectrum of the Bicuspid Aortic Valve Condition: Complex-Presentation Valvulo-Aortopathy.
    Circulation. 2020;142:294-299.
    PubMed    
    
    
    June 2020
73. ABBAS AE
    Letter by Abbas Regarding Articles, "Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the FRANCE-TAVI Registry" and "Impact of Sapien 3 Balloon-Expandable Versus Evolut R Self-Expand
    Circulation. 2020;141:e908-e909.
    PubMed    
    
    
    
74. DEHARO P, Bisson A, Saint Etienne C, Fauchier L, et al
    Response by Deharo et al to Letter Regarding Article, "Impact of Sapien 3 Balloon-Expandable Versus Evolut R Self-Expandable Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis: Data From a Nationwide Analysis".
    Circulation. 2020;141:e912-e913.
    PubMed    
    
    
    
75. VINCENT F, Ternacle J, Delhaye C, Auffret V, et al
    Response by Vincent et al to Letter Regarding Article, "Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the FRANCE-TAVI Registry".
    Circulation. 2020;141:e910-e911.
    PubMed    
    
    
    
76. ARTIACH G, Carracedo M, Plunde O, Wheelock CE, et al
    Omega-3 Polyunsaturated Fatty Acids Decrease Aortic Valve Disease through the Resolvin E1 and ChemR23 Axis.
    Circulation. 2020 Jun 8. doi: 10.1161/CIRCULATIONAHA.119.041868.
    PubMed     Abstract available
    
    
    
77. TAM DY, Wijeysundera HC, Naimark D, Gaudino M, et al
    Impact of Transcatheter Aortic Valve Durability on Life Expectancy in Low Risk Patients with Severe Aortic Stenosis.
    Circulation. 2020 Jun 4. doi: 10.1161/CIRCULATIONAHA.119.044559.
    PubMed     Abstract available
    
    
    
78. 
    Correction to: Infective Endocarditis After Transcatheter Aortic Valve Implantation: Results From a Large Multicenter Registry.
    Circulation. 2020;141:e879.
    PubMed    
    
    
    May 2020
79. 
    Correction to: Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990-2017.
    Circulation. 2020;141:e836.
    PubMed    
    
    
    
80. PETERZAN MA, Clarke WT, Lygate CA, Lake HA, et al
    Cardiac Energetics in Patients with Aortic Stenosis and Preserved versus Reduced Ejection Fraction.
    Circulation. 2020 May 22. doi: 10.1161/CIRCULATIONAHA.119.043450.
    PubMed     Abstract available
    
    
    
81. STROM JB, Faridi KF, Butala NM, Zhao Y, et al
    Use of Administrative Claims to Assess Outcomes and Treatment Effect in Randomized Clinical Trials for Transcatheter Aortic Valve Replacement: Findings from the Extending Trial-Based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND
    Circulation. 2020 May 21. doi: 10.1161/CIRCULATIONAHA.120.046159.
    PubMed     Abstract available
    
    
    
82. DELGADO V, Kumbhani DJ
    Cardiac and Vascular Changes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Aortic Stenosis.
    Circulation. 2020;141:1538-1540.
    PubMed    
    
    
    April 2020
83. MARSTRAND P, Han L, Day SM, Olivotto I, et al
    Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction: Insights From the SHaRe Registry.
    Circulation. 2020;141:1371-1383.
    PubMed     Abstract available
    
    
    
84. PIBAROT P, Salaun E, Dahou A, Avenatti E, et al
    Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial.
    Circulation. 2020 Apr 10. doi: 10.1161/CIRCULATIONAHA.119.044574.
    PubMed     Abstract available
    
    
    
85. LI S, Nguyen NUN, Xiao F, Menendez-Montes I, et al
    Mechanism of Eccentric Cardiomyocyte Hypertrophy Secondary to Severe Mitral Regurgitation.
    Circulation. 2020 Apr 10. doi: 10.1161/CIRCULATIONAHA.119.043939.
    PubMed     Abstract available
    
    
    March 2020
86. WEISSLER-SNIR A, Dorian P
    Response by Weissler-Snir and Dorian to Letter Regarding Article, "Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario".
    Circulation. 2020;141:e703-e704.
    PubMed    
    
    
    
87. MADIAS JE
    Letter by Madias Regarding Article, "Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario".
    Circulation. 2020;141:e701-e702.
    PubMed    
    
    
    
88. YADGIR S, Johnson CO, Aboyans V, Adebayo OM, et al
    Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990-2017.
    Circulation. 2020 Mar 29. doi: 10.1161/CIRCULATIONAHA.119.043391.
    PubMed     Abstract available
    
    
    
89. TOEPFER CN, Garfinkel AC, Venturini G, Wakimoto H, et al
    Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy.
    Circulation. 2020;141:828-842.
    PubMed     Abstract available
    
    
    February 2020
90. HALIM SA, Edwards FH, Dai D, Li Z, et al
    Outcomes of Transcatheter Aortic Valve Replacement in Patients with Bicuspid Aortic Valve Disease: A Report from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
    Circulation. 2020 Feb 26. doi: 10.1161/CIRCULATIONAHA.119.040333.
    PubMed     Abstract available
    
    
    January 2020
91. ABDEL-WAHAB M, Thiele H
    Transcatheter Heart Valve Design and Mortality: Truth or Dare?
    Circulation. 2020;141:269-272.
    PubMed    
    
    
    
92. LUETKENS JA, Faron A, Geissler HL, Al-Kassou B, et al
    Opportunistic Computed Tomography Imaging for the Assessment of Fatty Muscle Fraction Predicts Outcome in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Circulation. 2020;141:234-236.
    PubMed    
    
    
    
93. 
    Correction to: Slower Progress of Aortic Valve Calcification With Vitamin K Supplementation: Results From a Prospective Interventional Proof-of-Concept Study.
    Circulation. 2020;141:e54.
    PubMed    
    
    
    
94. KIM AJ, Xu N, Umeyama K, Hulin A, et al
    Deficiency of Circulating Monocytes Ameliorates the Progression of Myxomatous Valve Degeneration in Marfan Syndrome.
    Circulation. 2020;141:132-146.
    PubMed     Abstract available
    
    
    
95. FAYSSOIL A
    Letter by Fayssoil Regarding Article, "Excess Mortality Associated With Functional Tricuspid Regurgitation Complicating Heart Failure With Reduced Ejection Fraction".
    Circulation. 2020;141:e1-e2.
    PubMed    
    
    
    December 2019
96. KITKUNGVAN D, Yang EY, El Tallawi KC, Nagueh SF, et al
    Prognostic Implications of Diffuse Interstitial Fibrosis in Asymptomatic Primary Mitral Regurgitation.
    Circulation. 2019;140:2122-2124.
    PubMed    
    
    
    November 2019
97. SLOSTAD BD, Witt CM, O'Leary PW, Maleszewski JJ, et al
    Unicuspid Aortic Valve: Demographics, Comorbidities, Echocardiographic Features, and Long-Term Outcomes.
    Circulation. 2019;140:1853-1855.
    PubMed    
    
    
    
98. VAN BELLE E, Vincent F, Labreuche J, Auffret V, et al
    Balloon-Expandable versus Self-Expanding Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison from The France-TAVI Registry.
    Circulation. 2019 Nov 16. doi: 10.1161/CIRCULATIONAHA.119.043785.
    PubMed     Abstract available
    
    
    
99. DEHARO P, Bisson A, Herbert J, Lacour T, et al
    Impact of Sapien 3 Balloon-Expandable Versus Evolut R Self-Expandable Transcatheter Aortic Valve Implantation in Patients with Aortic Stenosis: Data from a Nationwide Analysis.
    Circulation. 2019 Nov 16. doi: 10.1161/CIRCULATIONAHA.119.043971.
    PubMed     Abstract available
    
    
    
100. RAGGI P, Bellasi A, Bushinsky D, Bover J, et al
     Slowing Progression of Cardiovascular Calcification with SNF472 in Patients on Hemodialysis: Results of a Randomized, Phase 2b Study.
     Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044195.
     PubMed     Abstract available
     
     
     October 2019
101. KANEKO T
     Killing Two Birds With One Stone: Complete Percutaneous Approach to Aortic Valve Replacement and Revascularization.
     Circulation. 2019;140:1306-1307.
     PubMed    
     
     
     
102. KATO N, Padang R, Pislaru C, Miranda WR, et al
     Hemodynamics and Prognostic Impact of Concomitant Mitral Stenosis in Patients Undergoing Surgical or Transcatheter Aortic Valve Replacement for Aortic Stenosis.
     Circulation. 2019;140:1251-1260.
     PubMed     Abstract available
     
     
     
103. DONNELLAN E, Alashi A, Johnston DR, Gillinov AM, et al
     Outcomes of Patients With Mediastinal Radiation-Associated Mitral Valve Disease Undergoing Cardiac Surgery.
     Circulation. 2019;140:1288-1290.
     PubMed    
     
     
     
104. RUEL M, Gardner TJ
     Introduction to the 2019 Cardiovascular Surgery-Themed Issue.
     Circulation. 2019;140:1231-1232.
     PubMed    
     
     
     September 2019
105. BONOW RO, Mark DB, O'Gara PT
     Coapting Cost and Clinical Outcomes in Transcatheter Intervention for Secondary Mitral Regurgitation.
     Circulation. 2019 Sep 29. doi: 10.1161/CIRCULATIONAHA.119.043408.
     PubMed    
     
     
     
106. BARON SJ, Wang K, Arnold SV, Magnuson EA, et al
     Cost-Effectiveness of Transcatheter Mitral Valve Repair versus Medical Therapy in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial.
     Circulation. 2019 Sep 29. doi: 10.1161/CIRCULATIONAHA.119.043275.
     PubMed     Abstract available
     
     
     
107. DESAI MY, Svensson LG
     Chronic Severe Aortic Regurgitation: Should We Lower Operating Thresholds?
     Circulation. 2019;140:1045-1047.
     PubMed    
     
     
     
108. BENNETT AJ, Carter S, Joglar JA
     A New Tachyarrhythmia in a 60-Year-Old Woman.
     Circulation. 2019;140:965-968.
     PubMed    
     
     
     August 2019
109. KHIRFAN G, Ahmed MK, Almaaitah S, Almoushref A, et al
     Comparison of Different Methods to Estimate Cardiac Index in Pulmonary Arterial Hypertension.
     Circulation. 2019;140:705-707.
     PubMed    
     
     
     July 2019
110. MITAL S, Ommen S
     To Screen or Not to Screen, That Is the Question.
     Circulation. 2019;140:193-195.
     PubMed    
     
     
     
111. SIGWART U
     Therapeutic Myocardial Infarction for Hypertrophic Obstructive Cardiomyopathy: Is It Appropriate?
     Circulation. 2019;140:11-12.
     PubMed    
     
     
     June 2019
112. MIRTSCHINK P, Bischof C, Pham MD, Sharma R, et al
     Inhibition of the Hypoxia-Inducible Factor 1alpha-Induced Cardiospecific HERNA1 Enhance-Templated RNA Protects From Heart Disease.
     Circulation. 2019;139:2778-2792.
     PubMed     Abstract available
     
     
     May 2019
113. SMITH GL, Eisner DA
     Calcium Buffering in the Heart in Health and Disease.
     Circulation. 2019;139:2358-2371.
     PubMed     Abstract available
     
     
     March 2019
114. MARON BJ, Rowin EJ, Maron MS
     Letter by Maron et al Regarding Article, "Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)".
     Circulation. 2019;139:1557-1558.
     PubMed    
     
     
     
115. HO CY, Day SM, Ashley EA, Michels M, et al
     Response by Ho et al to Letter Regarding Article, "Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)".
     Circulation. 2019;139:1559-1560.
     PubMed    
     
     
     
116. LEHMAN SJ, Tal-Grinspan L, Lynn ML, Strom J, et al
     Chronic Calmodulin-Kinase II Activation Drives Disease Progression in Mutation-Specific Hypertrophic Cardiomyopathy.
     Circulation. 2019;139:1517-1529.
     PubMed     Abstract available
     
     
     February 2019
117. CARRIER L
     Making Sense of Inhibiting Nonsense in Hypertrophic Cardiomyopathy.
     Circulation. 2019;139:812-814.
     PubMed    
     
     
     
118. UDELSON JE
     Evaluating and Reducing the Risk of Sudden Death in Hypertrophic Cardiomyopathy.
     Circulation. 2019;139:727-729.
     PubMed    
     
     
     
119. MAURIZI N, Michels M, Rowin EJ, Semsarian C, et al
     Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy.
     Circulation. 2019;139:830-833.
     PubMed    
     
     
     
120. SEEGER T, Shrestha R, Lam CK, Chen C, et al
     A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay.
     Circulation. 2019;139:799-811.
     PubMed     Abstract available
     
     
     
121. LEE DP, Tan WLW, Anene-Nzelu CG, Lee CJM, et al
     A Robust CTCF-Based Chromatin Architecture Underpins Epigenetic Changes in the Heart Failure Stress-Gene Response.
     Circulation. 2019 Feb 5. doi: 10.1161/CIRCULATIONAHA.118.036726.
     PubMed     Abstract available
     
     
     October 2018
122. YAGISHITA A, Goya M, Hirao K
     Simultaneous Recording of the P Wave During Atrial Fibrillation.
     Circulation. 2018;138:2057-2060.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: